TIMP-1 and responsiveness to gemcitabine in advanced breast cancer - Result

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Research output: Contribution to journal › Journal article › Research › peer-review

Documents

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
Final published version, 618 KB, PDF document

Charlotte Levin Tykjær Jørgensen
Christina Annette Bjerre
Ejlertsen, Bent Laursen
Karsten D. Bjerre
Eva Balslev
Bartels, Annette Snejbjerg
Nils Brünner
Dorte L. Nielsen

Original language	English
Article number	360
Journal	B M C Cancer
Volume	14
Number of pages	14
ISSN	1471-2407
DOIs	https://doi.org/10.1186/1471-2407-14-360
Publication status	Published - 2014

Research areas

TIMP-1, Gemcitabine, Docetaxel, Breast cancer, Prediction, Prognosis

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 125791294